• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙磷酸盐嵌入的 PLGA 纳米颗粒:一种具有高基因载量和转染效率的有前途的基因传递载体。

Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.

机构信息

College of Pharmacy, State Key Laboratory of Biotherapy, Sichuan University, No. 17, Section 3, Renmin Nan Road, Chengdu 610041, PR China.

出版信息

Int J Pharm. 2012 Jul 15;431(1-2):210-21. doi: 10.1016/j.ijpharm.2012.04.046. Epub 2012 Apr 23.

DOI:10.1016/j.ijpharm.2012.04.046
PMID:22561795
Abstract

In the purpose of increasing incorporation efficiency and improving the release kinetics of plasmid DNA (pDNA) from poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles, a facile method for the fabrication of calcium phosphate (CaPi) embedded PLGA nanoparticles (CaPi-pDNA-PLGA-NPs) was developed. The effect of several preparation factors on the particle size, incorporation efficiency, pDNA release and transfection efficiency in vitro was studied by Single Factor Screening Method. These preparation factors included the molecular weight (MW), hydrolysis degree (HD) of polyvinyl alcohol (PVA), sonication power and time, composition of organic phase, initial concentration of calcium phosphate and calcium (Ca) to phosphate ion (P) ratio (Ca/P ratio), etc. The CaPi-pDNA-PLGA-NPs made according to the optimal formulation were spherical in shape observed by transmission electron microscopy (TEM) with a mean particle size of 207±5 nm and an entrapment efficiency of 95.7±0.8%. Differential scanning calorimetry (DSC) suggested that there existed interaction between the DNA-calcium-phosphate (CaPi-pDNA) complexes and the polymeric matrices of PLGA. X-ray diffractometry (XRD) further proved the conclusion and indicated that the CaPi-pDNA was in weak crystallization form inside the nanoparticles. The Brunauer-Emmett-Teller (BET) surface area measurement demonstrated that the CaPi-pDNA-PLGA-NPs are mesoporous with specific surface area of 57.5m(2)/g and an average pore size of 96.5 Å. The transfection efficiency of the CaPi-pDNA-PLGA-NPs on human embryonic kidney 293 (HEK 293) cells in vitro was 22.4±1.2%, which was much higher than those of both the pDNA loaded PLGA nanoparticles (pDNA-PLGA-NPs) and the CaPi-pDNA embedded PLGA microparticles (CaPi-pDNA-PLGA-MPs). The CaPi-pDNA-PLGA-NPs are promising vectors for gene delivery.

摘要

为了提高质粒 DNA(pDNA)从聚(D,L-乳酸-共-乙醇酸)(PLGA)纳米粒中的包封效率和释放动力学,开发了一种简便的制备嵌入磷酸钙(CaPi)的 PLGA 纳米粒(CaPi-pDNA-PLGA-NPs)的方法。通过单因素筛选法研究了几种制备因素对粒径、包封效率、pDNA 释放和体外转染效率的影响。这些制备因素包括聚乙烯醇(PVA)的分子量(MW)、水解度(HD)、超声功率和时间、有机相组成、磷酸钙和钙(Ca)初始浓度以及钙/磷(Ca/P)比等。根据最佳配方制备的 CaPi-pDNA-PLGA-NPs 呈球形,透射电子显微镜(TEM)观察平均粒径为 207±5nm,包封效率为 95.7±0.8%。差示扫描量热法(DSC)表明,DNA-磷酸钙(CaPi-pDNA)复合物与 PLGA 聚合物基质之间存在相互作用。X 射线衍射(XRD)进一步证实了这一结论,并表明 CaPi-pDNA 在内纳米粒中呈弱结晶形式。BET 比表面积测量表明,CaPi-pDNA-PLGA-NPs 是介孔的,比表面积为 57.5m(2)/g,平均孔径为 96.5Å。体外人胚肾 293(HEK 293)细胞中 CaPi-pDNA-PLGA-NPs 的转染效率为 22.4±1.2%,明显高于负载 pDNA 的 PLGA 纳米粒(pDNA-PLGA-NPs)和嵌入磷酸钙的 PLGA 微球(CaPi-pDNA-PLGA-MPs)。CaPi-pDNA-PLGA-NPs 是一种很有前途的基因传递载体。

相似文献

1
Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.钙磷酸盐嵌入的 PLGA 纳米颗粒:一种具有高基因载量和转染效率的有前途的基因传递载体。
Int J Pharm. 2012 Jul 15;431(1-2):210-21. doi: 10.1016/j.ijpharm.2012.04.046. Epub 2012 Apr 23.
2
[Preparation and in vitro evaluation of pDNA-CaPi-PLGA nanoparticles with a core-shell structure].具有核壳结构的质粒DNA-磷酸钙-聚乳酸-羟基乙酸共聚物纳米粒的制备及体外评价
Yao Xue Xue Bao. 2013 Feb;48(2):298-304.
3
Facile Construction of Chloroquine Containing PLGA-Based pDNA Delivery System for Efficient Tumor and Pancreatitis Targeting in Vitro and in Vivo.基于聚乳酸-羟基乙酸共聚物构建含氯喹的质粒DNA递送系统,用于高效体外和体内肿瘤及胰腺炎靶向治疗
Mol Pharm. 2015 Jun 1;12(6):2167-79. doi: 10.1021/acs.molpharmaceut.5b00155. Epub 2015 May 21.
4
Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.壳聚糖修饰的聚(D,L-乳酸-共-乙醇酸)纳米球用于质粒 DNA 递送和 HBV 基因沉默。
Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.
5
Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.光化学内化用于 pDNA 转染:聚(丙交酯-共-乙交酯)和聚乙烯亚胺纳米粒的评价。
Int J Pharm. 2011 Jan 17;403(1-2):276-84. doi: 10.1016/j.ijpharm.2010.10.040. Epub 2010 Oct 29.
6
Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.替尼泊苷 PLGA 纳米粒的制备及表征及其在人胶质母细胞瘤 U87MG 细胞中的摄取。
Int J Pharm. 2012 Oct 15;436(1-2):815-24. doi: 10.1016/j.ijpharm.2012.07.050. Epub 2012 Jul 28.
7
Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.改良的纳米沉淀法制备载 DNA 的 PLGA 纳米粒。
Drug Dev Ind Pharm. 2009 Nov;35(11):1375-83. doi: 10.3109/03639040902939221.
8
Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery.经支化聚乙烯亚胺修饰的可生物降解纳米颗粒用于质粒 DNA 递送。
Biomaterials. 2010 Jan;31(1):133-43. doi: 10.1016/j.biomaterials.2009.09.024. Epub 2009 Sep 26.
9
Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.可生物降解微球的合理设计、制备、表征和体外测试,该微球可在 HepG2 肝细胞中产生靶向和持续的转基因表达。
J Drug Target. 2011 Jul;19(6):393-408. doi: 10.3109/1061186X.2010.504263. Epub 2010 Aug 3.
10
In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.负载紫杉醇的甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒对喉癌细胞的体外评价
Anticancer Drugs. 2009 Oct;20(9):807-14. doi: 10.1097/CAD.0b013e328330c811.

引用本文的文献

1
Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear.探索内耳中基于靶向纳米技术的基因治疗的递药系统。
Ther Deliv. 2024;15(10):801-818. doi: 10.1080/20415990.2024.2389032. Epub 2024 Sep 26.
2
Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer's disease.用于有效治疗阿尔茨海默病的卡巴拉汀聚合物纳米粒的制备与表征
Saudi Pharm J. 2024 May;32(5):102048. doi: 10.1016/j.jsps.2024.102048. Epub 2024 Mar 22.
3
Advanced Drug Delivery Systems for Renal Disorders.
用于肾脏疾病的先进药物递送系统
Gels. 2023 Feb 1;9(2):115. doi: 10.3390/gels9020115.
4
Preparation and application of calcium phosphate nanocarriers in drug delivery.磷酸钙纳米载体在药物递送中的制备与应用
Mater Today Bio. 2022 Nov 22;17:100501. doi: 10.1016/j.mtbio.2022.100501. eCollection 2022 Dec 15.
5
PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters.通过乳化和纳米沉淀技术制备聚乳酸-羟基乙酸共聚物纳米颗粒制剂:配方参数的影响
RSC Adv. 2020 Jan 27;10(8):4218-4231. doi: 10.1039/c9ra10857b. eCollection 2020 Jan 24.
6
The impact of calcium phosphate on FITC-BSA loading of sonochemically prepared PLGA nanoparticles for inner ear drug delivery elucidated by two different fluorimetric quantification methods.通过两种不同的荧光定量方法阐明了磷酸钙对声化学制备的用于内耳药物输送的 PLGA 纳米粒中 FITC-BSA 负载的影响。
Ultrason Sonochem. 2021 Nov;79:105783. doi: 10.1016/j.ultsonch.2021.105783. Epub 2021 Oct 9.
7
Biological and Medical Applications of Calcium Phosphate Nanoparticles.钙磷纳米粒子的生物与医学应用。
Chemistry. 2021 May 12;27(27):7471-7488. doi: 10.1002/chem.202005257. Epub 2021 Mar 16.
8
Folic Acid/Peptides Modified PLGA-PEI-PEG Polymeric Vectors as Efficient Gene Delivery Vehicles: Synthesis, Characterization and Their Biological Performance.叶酸/肽修饰的 PLGA-PEI-PEG 聚合物载体作为高效基因传递载体:合成、表征及其生物学性能。
Mol Biotechnol. 2021 Jan;63(1):63-79. doi: 10.1007/s12033-020-00285-5. Epub 2020 Nov 3.
9
Calcium Phosphate Nanoparticles-Based Systems for RNAi Delivery: Applications in Bone Tissue Regeneration.基于磷酸钙纳米颗粒的RNA干扰递送系统:在骨组织再生中的应用
Nanomaterials (Basel). 2020 Jan 14;10(1):146. doi: 10.3390/nano10010146.
10
Enhanced Transfection of Human Mesenchymal Stem Cells Using a Hyaluronic Acid/Calcium Phosphate Hybrid Gene Delivery System.使用透明质酸/磷酸钙混合基因递送系统增强人间充质干细胞的转染
Polymers (Basel). 2019 May 4;11(5):798. doi: 10.3390/polym11050798.